ArticleThe Eurasian journal of medicine2026
Evaluation of Diabetes Mellitus, Hyperlipidemia, and Thyroid Disease Comorbidities in Palmoplantar Pustulosis.
Article in The Eurasian journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPalmoplantar pustulosis (PPP) is a chronic, inflammatory pustular skin disease of unknown etiology. Genetic predisposition, smoking, focal infections, stress, and autoimmune diseases are implicated in its etiology. In this study, the presence of thyroid disease, diabetes mellitus (DM), and dyslipidemia in PPP was investigated based on comorbidities in psoriasis.
methodsThe records of 51 patients who were diagnosed with PPP both clinically and histopathologically and presented to the dermatology clinic were examined retrospectively. In these patients, fasting blood sugar, HbA1C, serum lipids (cholesterol, triglyceride, low-density lipoprotein (LDL), high-density lipoprotein (HDL)), thyroid-stimulating hormone (TSH), free thyroxine (ft4), free triiodothyronine (ft3), antithyroglobulin (antiTG), antithyroid peroxidase antibody (antiTPO) were recorded, and the presence of DM, dyslipidemia, and thyroid disease was investigated. Compared with the control group.
resultsThe average age of the patients was 47.9 (Å}12.1) years and the average disease duration was 5 (3-12) years. In the patients, hypertriglyceridemia was found in 29.4%, hypercholesterolemia in 45.1%, high LDL in 44%, low HDL in 14%, thyroid disease in 11.76%, and DM in 21.5%. When these values were compared with the control group, triglyceride values were significantly higher in the patients compared to the controls (P < .001).
conclusionsBased on the data of this study, as in psoriasis, it could be suggested that there is a possibility of DM, dyslipidemia, and thyroid disease comorbidity with PPP. Cite this article as: Akbaş A, Kılın. F, Şener S, Hayran Y. Evaluation of diabetes mellitus, hyperlipidemia, and thyroid disease comorbidities in palmoplantar pustulosis. Eurasian J Med. 2026, 58(2), 1026, doi:10.5152/eurasianjmed.2026.251026.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.